When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

ByHeart, a manufacturer of organic baby formula, recalled all of its products sold nationwide Tuesday, days after some batches were recalled in an expanding outbreak of infant botulism. At least 15 ...

An outbreak of botulism tied to ByHeart baby formula has made at least 15 infants sick in 12 states, a California health official said Monday. The company announced Tuesday that it is expanding its ...

Federal health officials said caregivers should stop using all ByHeart powdered formula products after 15 infants in 12 states were hospitalized. By Rylee Kirk ByHeart, a maker of organic baby formula ...

With their sleek lines, smoking tyres and thunderous engines, Formula 1 cars have been the fastest road vehicles for the past 50 years. But electric vehicles may soon become the quickest on Earth, as ...

Health agencies asked caregivers to stop using two batches of ByHeart Whole Nutrition Infant Formula after they found an increase in cases of infant botulism. By Amanda Holpuch Update: ByHeart ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

We recently published 10 Big Names With Explosive Growth. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Wednesday. Recursion Pharmaceuticals jumped by 16.44 percent on ...